These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3690588)

  • 1. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans.
    Mercuro G; Rossetti ZL; Rivano CA; Ruscazio M; Tocco L; Gessa G; Cherchi A
    Hypertension; 1987 Jan; 9(1):35-40. PubMed ID: 3793199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DA2-type dopamine receptors: the physiological and clinical implications in cardiology].
    Mercuro G; Rivano CA; Lai L; Longu G; Cherchi A
    Cardiologia; 1987 Dec; 32(12):1623-30. PubMed ID: 2965981
    [No Abstract]   [Full Text] [Related]  

  • 5. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated development of hypertension by chronic administration of bromocriptine in Doca-salt hypertensive rats.
    Kambara S; Yoshimura M; Okabayashi H; Takahashi H; Ijichi H
    Jpn Circ J; 1986 Nov; 50(11):1120-7. PubMed ID: 3102804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the hypotensive effect of apomorphine].
    Montastruc JL; Guiol C
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1176-80. PubMed ID: 6441536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
    Mercuro G; Rossetti ZL; Tocco L; Rivano CA; Cherchi A; Gessa GL
    Eur J Clin Pharmacol; 1985; 27(6):671-5. PubMed ID: 3987772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure effects of apomorphine and domperidone in parkinsonism.
    Pollak P; Mallaret M; Gaio JM; Hommel M; Perret J
    Adv Neurol; 1987; 45():263-6. PubMed ID: 3548261
    [No Abstract]   [Full Text] [Related]  

  • 11. Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
    Goiny M; Uvnäs-Moberg K; Cekan S
    Psychopharmacology (Berl); 1986; 89(1):108-12. PubMed ID: 3090584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypotensive effect of dopaminergic agonists in the rat].
    Prieto JC; Quevedo M; Sapunar J; Pérez-Olea J
    Arch Inst Cardiol Mex; 1987; 57(4):279-84. PubMed ID: 2960282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic control of sympathetic activity and blood pressure in haemodialysis patients.
    Sturani A; Degli Esposti E; De March A; Santoro A; Fuschini G; Zuccalà A; Chiarini C; Flamigni C; Zucchelli P
    Proc Eur Dial Transplant Assoc; 1983; 20():156-60. PubMed ID: 6657650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peripheral dopamine presynaptic receptors lowers blood pressure and heart rate in dogs.
    Taylor AA; Fennell WH; Feldman MB; Brandon TA; Ginos JZ; Mitchell JR
    Hypertension; 1983; 5(2):226-34. PubMed ID: 6826215
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is stimulation of prejunctional dopamine receptors an antihypertensive principle?
    Clark BJ
    Clin Exp Hypertens A; 1987; 9(5-6):1045-68. PubMed ID: 3304728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of DA2 peripheral receptors in the regulation of blood pressure in elderly hypertensive patients: effects of dihydroergotoxine mesylate and sulpiride].
    Lombardi C; De Cotiis R; Spedini C
    G Clin Med; 1987; 68(8-9):421-5. PubMed ID: 2961645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.